Over-the-counter medications may alter cancer immunotherapy outcomes
by Matt Talhelm, Duke University edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Two patients who are being treated with immunotherapy for identical cancers may exhibit differential responses due to taking different medications. PPI, proton pump inhibitor; TMB, tumor mutational burden. Credit: Journal of Clinical Oncology (2026). DOI: 10.1200/jco-25-01811 Immunotherapy is offering […]
Over-the-counter medications may alter cancer immunotherapy outcomes Read More »
